Terms: = Cervical cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
15 results:
1. Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs.
Zhang W; Lu Y; Zang Y; Han J; Xiong Q; Xiong J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163150
[TBL] [Abstract] [Full Text] [Related]
2. In vivo Multi-scale Photoacoustic Imaging Guided Photothermal Therapy of cervical cancer based on Customized Laser System and Targeted Nanoparticles.
Qiu T; Lan Y; Wei Z; Zhang Y; Lin Y; Tu C; Mao G; Zhang L; Yang B; Zhang J
Int J Nanomedicine; 2021; 16():2879-2896. PubMed ID: 33883896
[TBL] [Abstract] [Full Text] [Related]
3. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR).
Ye Y; Peng L; Vattai A; Deuster E; Kuhn C; Dannecker C; Mahner S; Jeschke U; von Schönfeldt V; Heidegger HH
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2189-2203. PubMed ID: 32488496
[TBL] [Abstract] [Full Text] [Related]
4. serpine1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
[TBL] [Abstract] [Full Text] [Related]
5. Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.
Zhang G; Miyake M; Lawton A; Goodison S; Rosser CJ
BMC Cancer; 2014 May; 14():310. PubMed ID: 24885595
[TBL] [Abstract] [Full Text] [Related]
6. Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.
Gomes-Giacoia E; Miyake M; Goodison S; Rosser CJ
Mol Cancer Ther; 2013 Dec; 12(12):2697-708. PubMed ID: 24072883
[TBL] [Abstract] [Full Text] [Related]
7. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
[TBL] [Abstract] [Full Text] [Related]
8. Nadroparine activated fibrinolysis and improvement of glomerular filtration rate in patients with FIGO IIB-IIIB cervical cancer treated with radiochemotherapy.
Derlatka P; Bidzinski M; Stachurska E; Benke M
Gynecol Oncol; 2007 Jan; 104(1):24-31. PubMed ID: 16959304
[TBL] [Abstract] [Full Text] [Related]
9. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
Whitley BR; Palmieri D; Twerdi CD; Church FC
Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
[TBL] [Abstract] [Full Text] [Related]
10. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line.
Lee S; Cho YS; Shim C; Kim J; Choi J; Oh S; Kim J; Zhang W; Lee J
Int J Cancer; 2001 Nov; 94(4):500-7. PubMed ID: 11745435
[TBL] [Abstract] [Full Text] [Related]
11. Proliferation in "atypical" atrophic pap smears.
Bulten J; de Wilde PC; Boonstra H; Gemmink JH; Hanselaar AG
Gynecol Oncol; 2000 Nov; 79(2):225-9. PubMed ID: 11063649
[TBL] [Abstract] [Full Text] [Related]
12. Clinical efficacy of applying four-field portals to paraaortic irradiation in the treatment of cervical carcinoma.
Kodaira T; Karasawa K; Shimizu T; Tanaka Y; Matsuda T; Murakami A; Mizutani K
Radiat Oncol Investig; 1999; 7(3):170-7. PubMed ID: 10406059
[TBL] [Abstract] [Full Text] [Related]
13. Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy.
Dong Y; Berners-Price SJ; Thorburn DR; Antalis T; Dickinson J; Hurst T; Qiu L; Khoo SK; Parsons PG
Biochem Pharmacol; 1997 Jun; 53(11):1673-82. PubMed ID: 9264320
[TBL] [Abstract] [Full Text] [Related]
14. Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
Nishida T; Nagasue N; Izumi S; Sakihama H; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):193-8. PubMed ID: 1690254
[TBL] [Abstract] [Full Text] [Related]
15. treatment of gynecological malignancies with a combination of cisplatin, adriamycin and ifosfamide.
Nishida T; Nagasue N; Yakushiji M
Cancer Chemother Pharmacol; 1990; 26 Suppl():S39-42. PubMed ID: 2347048
[TBL] [Abstract] [Full Text] [Related]
